Researchers at the universities in Stockholm and Lund, in collaboration with researchers from the University of California, have found a new toxin that selectively targets mosquitoes. This can lead to innovative and environmentally friendly approaches to reduce malaria. The results are presented in an article published in Nature Communications.
Botox (Botulinum neurotoxins) and the toxin causing tetanus belong to the same family of proteins and are among the most toxic substances known. Previously this family of toxins has been believed to only target vertebrates such as humans, mice and birds. But now, researchers have found a toxin which targets the group of mosquitoes that are responsible for transmitting malaria.
"We have discovered a neurotoxin, PMP1, that selectively targets malaria mosquitos, demonstrating that this family of toxins have a much broader host spectrum than previously believed," says PÃ¥l Stenmark of Stockholm University and Lund University. He leads the joint research group from the two Swedish universities that has discovered the new neurotoxin in close collaboration with Sarjeet Gill's research group at the University of California.
"PMP1 makes it possible to reduce the prevalence of malaria in a new and environmentally friendly way. Because these toxins are proteins, they do not leave any artificial residues as they decompose. PMP1 may also be developed into biological insecticides designed to target other selected disease vectors or pests", PÃ¥l Stenmark says.
Today, insecticides and mosquito nets treated with insecticides are the main means of combating the spread of malaria, but new methods of combating malaria mosquitoes must be developed constantly as mosquitoes become resistant to most toxins over time.
"We found PMP1 in a bacterium from two threatened habitats: a mangrove swamp in Malaysia and the forest floor in Brazil. It shows just how important it is to protect these treasure chests of biological diversity," Stenmark says.
The article "A neurotoxin that specifically targets Anopheles mosquitoes" is published in Nature Communications.
Building Infection Prevention Capacity in the Middle East: A 7-Year Certification Success Story
June 17th 2025Despite rapid development, the Middle East faces a critical shortage of certified infection preventionists. A 7-year regional initiative has significantly boosted infection control capacity, increasing the number of certified professionals and elevating patient safety standards across health care settings.
Streamlined IFU Access Boosts Infection Control and Staff Efficiency
June 17th 2025A hospital-wide quality improvement project has transformed how staff access critical manufacturer instructions for use (IFUs), improving infection prevention compliance and saving time through a standardized, user-friendly digital system supported by unit-based training and interdepartmental collaboration.
Swift Isolation Protocol Shields Chicago Children’s Hospital During 2024 Measles Surge
June 17th 2025When Chicago logged its first measles cases linked to crowded migrant shelters last spring, one pediatric hospital moved in hours—not days—to prevent the virus from crossing its threshold. Their playbook offers a ready template for the next communicable-disease crisis.
Back to Basics: Hospital Restores Catheter-Associated UTI Rates to Prepandemic Baseline
June 16th 2025A 758-bed quaternary medical center slashed catheter-associated urinary tract infections (CAUTIs) by 45% over 2 years, proving that disciplined adherence to fundamental prevention steps, not expensive add-ons, can reverse the pandemic-era spike in device-related harm.
Global Patients, Local Risks: Why Medical Tourism Demands Infection Preventionists’ Attention
June 16th 2025At APIC25, infection prevention leader Heather Stoltzfus, MPH, RN, CIC, will spotlight the growing risks and overlooked responsibilities associated with medical tourism. Her session urges infection preventionists to engage with a global health trend that directly impacts US care settings.